Correlation Between Cns Pharmaceuticals and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Cns Pharmaceuticals and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Cardio Diagnostics.
Diversification Opportunities for Cns Pharmaceuticals and Cardio Diagnostics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cns and Cardio is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Cardio Diagnostics
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the Cardio Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, Cns Pharmaceuticals is 1.69 times less risky than Cardio Diagnostics. The stock trades about -0.08 of its potential returns per unit of risk. The Cardio Diagnostics Holdings is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Cardio Diagnostics Holdings on August 28, 2024 and sell it today you would lose (4.00) from holding Cardio Diagnostics Holdings or give up 12.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cns Pharmaceuticals vs. Cardio Diagnostics Holdings
Performance |
| Timeline |
| Cns Pharmaceuticals |
| Cardio Diagnostics |
Cns Pharmaceuticals and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cns Pharmaceuticals and Cardio Diagnostics
The main advantage of trading using opposite Cns Pharmaceuticals and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.| Cns Pharmaceuticals vs. Capricor Therapeutics | Cns Pharmaceuticals vs. Soleno Therapeutics | Cns Pharmaceuticals vs. Bio Path Holdings | Cns Pharmaceuticals vs. Moleculin Biotech |
| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |